脑部放疗，上午比下午敏感许多！' x9 I: [* F- H/ X
3 a% _# S! K- t3 F" L$ v! N" |
* k1 l6 y7 G) \; N) r2 DCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.
% ~, B. s/ ~$ D8 s8 N' n" sGamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
- w" J: B# I# @/ R$ |0 j) a* JRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.# F! [! K9 L; I4 ~( q
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
# v% v! w. @8 b" {) g3 q
2 `- E7 p$ S- J, M# R5 tAbstract2 V% W* u. h, w8 H5 r m4 K( A
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.) w/ e \" t" Y* j& m1 x/ t3 {
) D& s- u9 k, N+ j
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.3 R1 ]: K( t0 }7 j
" J$ G9 n+ p& S8 U4 E/ O! N# r, L
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).1 a5 z' l7 M, j* ` V( ?# Q
/ E2 `' [. m% Y) R6 N& I2 o. d3 u
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.1 R5 n9 K+ H, h* j$ o1 U3 d
3 L# T2 \ A( _ r |
$ u) K" v# z" I& G9 i
显身卡
